# Phase 2b Controlled Study

> **NCT07140380** · PHASE2 · COMPLETED · sponsor: **IVIEW Therapeutics Inc.** · enrollment: 30 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** IVW-1001 Ophthalmic Eyelid Wipe

## Key facts

- **NCT ID:** NCT07140380
- **Lead sponsor:** IVIEW Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-20
- **Primary completion:** 2025-10-08
- **Final completion:** 2025-10-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07140380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07140380, "Phase 2b Controlled Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07140380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*